How to Design an Antibiotic Strategy That Respects the Indigenous Flora

  • Hans L. Bams


This chapter is meant to give practical guidelines on developing an antibiotic policy, bearing in mind the philosophy and goals [1] of selective decontamination of the digestive tract (SDD) as described in the earlier chapters of this book. These guidelines may be needed because SDD is meant to change the resident flora in such a way that secondary endogenous infections by that flora will not occur. As antibiotics given for (suspected) infection usually affect the resident flora, these antibiotics can easily interact in such a way as to conflict with the aims of SDD. Antibiotics can interact in several ways. They can inactivate the topical antibiotics used to achieve SDD, and they can also interact with the colonisation resistance. These guidelines will give some help in the choice of an antibiotic therapy that will allow both goals to be achieved: eliminating infection and persistence of colonisation resistance by unaffected gut flora with anaerobes and Gram-positive bacilli.


Antimicrobial Therapy Abdominal Sepsis Colonisation Resistance Antibiotic Strategy Resident Flora 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Stoutenbeek CP (1987) Infection prevention in multiple trauma patients by selective decontamination of the digestive tract. Thesis, ISBN 90-9001736-4Google Scholar
  2. 2.
    Giamarellou H (1980) Aminoglycosides plus beta-lactams against Gram-negative organisms. Evaluation of in vitro synergy and chemical interactions. Am J Med 80(6B):126–137Google Scholar
  3. 3.
    Flournoy DJ (1979) Factors influencing the inactivation of aminoglycosides by beta-lactams. Methods Find Exp Clin Pharmacol 1:233–238PubMedGoogle Scholar
  4. 4.
    Holtzheimer RG (2001) Antibiotic induced endotoxin release and clinical sepsis: a review. J Chemother 13:159–172Google Scholar
  5. 5.
    Van der Voort PH, Boerma EC, Yska JP (2007) Serum and peritoneal levels of amphotericin B and flucytosine during intravenous treatment of critically ill patients with Candida peritonitis. J Antimicrob Chemother 59:952–956PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • Hans L. Bams
    • 1
  1. 1.Skills CentreUniversity Hospital GroningenGroningenThe Netherlands

Personalised recommendations